High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI (HEROS-PCI)

NCT06924684 PHASE2 ACTIVE_NOT_RECRUITING

To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days

Details

Lead sponsor	Sheikh Zayed Federal Postgraduate Medical Institute
Phase	PHASE2
Status	ACTIVE_NOT_RECRUITING
Enrolment	66
Start date	Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jul 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• ST Elevation (STEMI) Myocardial Infarction

Interventions

• Statin monotherapy (rosuvastatin or atorvastatin)
• Placebo

Countries

Pakistan